213 related articles for article (PubMed ID: 15055992)
41. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
42. Characteristic of alkylated chalcones from Angelica keiskei on influenza virus neuraminidase inhibition.
Park JY; Jeong HJ; Kim YM; Park SJ; Rho MC; Park KH; Ryu YB; Lee WS
Bioorg Med Chem Lett; 2011 Sep; 21(18):5602-4. PubMed ID: 21824777
[TBL] [Abstract][Full Text] [Related]
43. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
Du QS; Wang SQ; Chou KC
Biochem Biophys Res Commun; 2007 Oct; 362(2):525-31. PubMed ID: 17707775
[TBL] [Abstract][Full Text] [Related]
44. Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent.
Atigadda VR; Brouillette WJ; Duarte F; Ali SM; Babu YS; Bantia S; Chand P; Chu N; Montgomery JA; Walsh DA; Sudbeck EA; Finley J; Luo M; Air GM; Laver GW
J Med Chem; 1999 Jul; 42(13):2332-43. PubMed ID: 10395473
[TBL] [Abstract][Full Text] [Related]
45. Novel potent macrocyclic inhibitors of the hepatitis C virus NS3 protease: use of cyclopentane and cyclopentene P2-motifs.
Bäck M; Johansson PO; Wångsell F; Thorstensson F; Kvarnström I; Ayesa S; Wähling H; Pelcman M; Jansson K; Lindström S; Wallberg H; Classon B; Rydergård C; Vrang L; Hamelink E; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2007 Nov; 15(22):7184-202. PubMed ID: 17845856
[TBL] [Abstract][Full Text] [Related]
46. A QSAR study on influenza neuraminidase inhibitors.
Verma RP; Hansch C
Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733
[TBL] [Abstract][Full Text] [Related]
47. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
48. Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.
Wang GT; Wang S; Gentles R; Sowin T; Maring CJ; Kempf DJ; Kati WM; Stoll V; Stewart KD; Laver G
Bioorg Med Chem Lett; 2005 Jan; 15(1):125-8. PubMed ID: 15582424
[TBL] [Abstract][Full Text] [Related]
49. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza.
McCullers JA
J Infect Dis; 2004 Aug; 190(3):519-26. PubMed ID: 15243927
[TBL] [Abstract][Full Text] [Related]
50. The novel L- and D-amino acid derivatives of hydroxyurea and hydantoins: synthesis, X-ray crystal structure study, and cytostatic and antiviral activity evaluations.
Opacić N; Barbarić M; Zorc B; Cetina M; Nagl A; Frković D; Kralj M; Pavelić K; Balzarini J; Andrei G; Snoeck R; De Clercq E; Raić-Malić S; Mintas M
J Med Chem; 2005 Jan; 48(2):475-82. PubMed ID: 15658861
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2-P3-ligands.
Ghosh AK; Kumaragurubaran N; Hong L; Kulkarni SS; Xu X; Chang W; Weerasena V; Turner R; Koelsch G; Bilcer G; Tang J
J Med Chem; 2007 May; 50(10):2399-407. PubMed ID: 17432843
[TBL] [Abstract][Full Text] [Related]
52. Virtual screening pipeline and ligand modelling for H5N1 neuraminidase.
D'Ursi P; Chiappori F; Merelli I; Cozzi P; Rovida E; Milanesi L
Biochem Biophys Res Commun; 2009 Jun; 383(4):445-9. PubMed ID: 19371724
[TBL] [Abstract][Full Text] [Related]
53. Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice.
Sidwell RW; Smee DF; Bailey KW; Burger RA
Int Immunopharmacol; 2001 Jun; 1(6):1211-8. PubMed ID: 11407315
[TBL] [Abstract][Full Text] [Related]
54. 2-Deoxy-2,3-didehydro-N-acetylneuraminic acid analogs structurally modified by thiocarbamoylalkyl groups at the C-4 position: Synthesis and biological evaluation as inhibitors of human parainfluenza virus type 1.
Ikeda K; Sato K; Nishino R; Aoyama S; Suzuki T; Sato M
Bioorg Med Chem; 2008 Jul; 16(14):6783-8. PubMed ID: 18555688
[TBL] [Abstract][Full Text] [Related]
55. Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain.
Shao PP; Ok D; Fisher MH; Garcia ML; Kaczorowski GJ; Li C; Lyons KA; Martin WJ; Meinke PT; Priest BT; Smith MM; Wyvratt MJ; Ye F; Parsons WH
Bioorg Med Chem Lett; 2005 Apr; 15(7):1901-7. PubMed ID: 15780630
[TBL] [Abstract][Full Text] [Related]
56. Syntheses of 2-deoxy-2,3-didehydro-N-acetylneuraminic acid analogues modified by N-sulfonylamidino groups at the C-4 position and biological evaluation as inhibitors of human parainfluenza virus type 1.
Nishino R; Ikeda K; Hayakawa T; Takahashi T; Suzuki T; Sato M
Bioorg Med Chem; 2011 Apr; 19(7):2418-27. PubMed ID: 21382718
[TBL] [Abstract][Full Text] [Related]
57. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
58. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.
Chen KX; Njoroge FG; Arasappan A; Venkatraman S; Vibulbhan B; Yang W; Parekh TN; Pichardo J; Prongay A; Cheng KC; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2006 Feb; 49(3):995-1005. PubMed ID: 16451065
[TBL] [Abstract][Full Text] [Related]
59. Stereospecific synthesis of 5-substituted 2-bisarylthiocyclopentane carboxylic acids as specific matrix metalloproteinase inhibitors.
Le Diguarher T; Chollet AM; Bertrand M; Hennig P; Raimbaud E; Sabatini M; Guilbaud N; Pierré A; Tucker GC; Casara P
J Med Chem; 2003 Aug; 46(18):3840-52. PubMed ID: 12930146
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
Krueger AC; Xu Y; Kati WM; Kempf DJ; Maring CJ; McDaniel KF; Molla A; Montgomery D; Kohlbrenner WE
Bioorg Med Chem Lett; 2008 Mar; 18(5):1692-5. PubMed ID: 18242993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
